by Cassie Arnold | Feb 9, 2021 | Biotech Finance, COVID, Deal making, Investment
If you had an inkling that more money went to vaccine and diagnostic companies in 2020, you were right. Diagnostics and vaccines have long been the red-headed stepchildren of life sciences investments. Detecting and treating life threatening diseases is the...
by Cassie Arnold | Jan 28, 2021 | Biotech Finance, Deal making, Digital Health, Digital Therapeutics, Investment
After starting off 2020 with a 35 percent drop in the number of deals from the previous quarter, digital therapeutic deal-making steadily climbed over the course of 2020 to total 71 deals for the year. With 25 deals in the fourth quarter of 2020, the index was up 44...
by Cassie Arnold | Jul 8, 2020 | Deal making, Digital Health, Digital Therapeutic, Investment
Digital therapeutic dealmaking bounced back to Q4 2019 levels in the second quarter of the year. After a first quarter where deal-making was stymied in by the onslaught of COVID-19, buyers came back big-time in the second quarter once the reality of the “new...
by Cassie Arnold | Apr 21, 2020 | Deal making, Digital Health, Digital Therapeutic, Investment
First quarter digital therapeutic deal data provided by DealForma shows a drop quarter-over-quarter from 16 transactions in the last quarter of 2019 to 11 in the first quarter of 2020. But year-over-year, the first quarter of 2020 is on par with the first quarter of...
